High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future

10.4158/EP161208.GL

10.1089/thy.2015.0020

10.1089/thy.2015.0300

10.1001/jama.2015.0956

10.1007/s00423-008-0366-7

10.1210/jc.2013-1806

10.1080/02656736.2016.1244707

10.1210/jc.2015-1964

10.1148/radiol.15141492

10.1148/radiol.2017161640

10.1007/s12020-018-1560-1

10.1002/jcu.1870070410

10.1002/cne.901030304

10.1126/science.122.3168.517

Fry, 1955, Ultrasonically produced localized selective lesions in the central nervous system, 413

10.3171/jns.1954.11.5.0471

10.1148/radiol.2352030916

10.1245/ASO.2004.02.026

10.1016/j.ultsonch.2004.01.011

10.1016/j.ultrasmedbio.2003.10.010

10.3748/wjg.v10.i15.2201

10.1111/j.1440-1746.2006.04719.x

10.1007/s00330-008-1137-0

10.1259/0007-1285-68-816-1296

10.3748/wjg.v19.i43.7494

10.5306/wjco.v2.i1.8

10.1089/thy.2016.0664

10.1186/s40349-017-0091-1

Lang, 2017, Vocal cord paresis following singlesession high intensity focused ablation (HIFU) treatment of benign thyroid nodules: incidence and risk factors, 888

10.1007/s00330-017-5200-6

10.1080/02656736.2017.1318456

10.1007/s00330-018-5579-8

10.1007/s00330-012-2671-3

10.1148/radiol.12111300

10.1007/s00330-018-5671-0

10.1148/radiol.2017162776

10.1007/s00330-014-3405-5

10.1089/thy.2015.0471

10.1080/02656736.2017.1361047

10.1080/02656736.2018.1516302

10.1186/s40349-015-0029-4

10.1259/bjr.20170641

Napoletano, 2008, RFA strongly modulates the immune system and antitumor immune responses in metastatic liver patients, 481

10.1121/1.4812893